Glenmark Life Sciences to become Alivus Life Sciences after acquisition by Nirma Limited, pending shareholder approval and ...

Glenmark Pharmaceuticals Ltd is quoting at Rs 1712.1, up 2.21% on the day as on 12:49 IST on the NSE. The stock is up 118.27% in last one year as compared to a 27.62% spurt in NIFTY and a 53.45% spurt ...

In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has ...

IST, the barometer index, the S&P BSE Sensex gained 355.51 points or 0.43% to 81,986.03. The Nifty 50 index added 125.90 points or 0.50% to 25,139.05.

Healthcare professionals and pharmaceutical stakeholders emphasise the need for clearer distinctions to prevent ...

Glenmark Pharmaceuticals Limited (Glenmark), a research-led, global pharmaceutical company, and a leader in cardiovascular disease management, today launched the “Take Charge @18” movement at the ...

The Nifty Pharma index closed on a positive note on Tuesday. Shares of Glenmark Pharmaceuticals Ltd.(up 3.55 per cent), Ipca ...

VMPL Hyderabad Telangana [India] October 8 Messe Muenchen India successfully concluded its highly anticipated and largest ...

The Indian Pharmaceutical Alliance (IPA) emphasizes the need to distinguish between spurious and sub-standard drugs. A recent ...

The Indian Pharma Alliance (IPA), representing 23 pharma companies like Sun Pharma, Lupin and Cipla, stressed that NSQ and ...

More than 50 drugs for common conditions like high blood pressure, acid reflux, and erectile dysfunction have been found to ...